Caricamento...
Tamoxifen Action in ER-Negative Breast Cancer
Breast cancer is a highly heterogeneous disease. Tamoxifen is a selective estrogen receptor (ER) modulator and is mainly indicated for the treatment of breast cancer in postmenopausal women and postsurgery neoadjuvant therapy in ER-positive breast cancers. Interestingly, 5–10% of the ER-negative bre...
Salvato in:
| Pubblicato in: | Sign Transduct Insights |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792287/ https://ncbi.nlm.nih.gov/pubmed/26989346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/STI.S29901 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|